These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


79 related items for PubMed ID: 7895527

  • 21. Quantitative flow cytometry can distinguish between normal and leukaemic B-cell precursors.
    Farahat N, Lens D, Zomas A, Morilla R, Matutes E, Catovsky D.
    Br J Haematol; 1995 Nov; 91(3):640-6. PubMed ID: 8555067
    [Abstract] [Full Text] [Related]

  • 22. The impact of acute and chronic graft-versus-host disease on normal and malignant B-lymphoid precursors after allogeneic stem cell transplantation for B-lineage acute lymphoblastic leukemia.
    Sánchez-García J, Serrano J, Gómez P, Martínez F, Martín C, Román-Gómez J, Rodríguez A, Herrera C, García JM, Alvarez MA, Torres A.
    Haematologica; 2006 Mar; 91(3):340-7. PubMed ID: 16531257
    [Abstract] [Full Text] [Related]

  • 23. Mixed lineage leukemia-rearranged childhood pro-B and CD10-negative pre-B acute lymphoblastic leukemia constitute a distinct clinical entity.
    Attarbaschi A, Mann G, König M, Steiner M, Strehl S, Schreiberhuber A, Schneider B, Meyer C, Marschalek R, Borkhardt A, Pickl WF, Lion T, Gadner H, Haas OA, Dworzak MN.
    Clin Cancer Res; 2006 May 15; 12(10):2988-94. PubMed ID: 16707593
    [Abstract] [Full Text] [Related]

  • 24. Comparison of diagnostic and relapse flow cytometry phenotypes in childhood acute lymphoblastic leukemia: implications for residual disease detection: a report from the children's oncology group.
    Borowitz MJ, Pullen DJ, Winick N, Martin PL, Bowman WP, Camitta B.
    Cytometry B Clin Cytom; 2005 Nov 15; 68(1):18-24. PubMed ID: 16184615
    [Abstract] [Full Text] [Related]

  • 25. Differential kinetics of engraftment and induction of CD10 on human pre-B leukemia cell lines in immune deficient scid mice.
    Kamel-Reid S, Dick JE, Greaves A, Murdoch B, Doedens M, Grunberger T, Thorner P, Freedman MH, Phillips RA, Letarte M.
    Leukemia; 1992 Jan 15; 6(1):8-17. PubMed ID: 1531243
    [Abstract] [Full Text] [Related]

  • 26. Automated detection of residual leukemic cells by consecutive immunolabeling for CD10 and fluorescence in situ hybridization for ETV6/RUNX1 rearrangement in childhood acute lymphoblastic leukemia.
    Alpár D, Kajtár B, Kneif M, Jáksó P, László R, Kereskai L, Pajor L.
    Cancer Genet Cytogenet; 2007 Feb 15; 173(1):23-30. PubMed ID: 17284366
    [Abstract] [Full Text] [Related]

  • 27. Clinical significance of CD10 expression in childhood acute lymphoblastic leukemia.
    Pui CH, Rivera GK, Hancock ML, Raimondi SC, Sandlund JT, Mahmoud HH, Ribeiro RC, Furman WL, Hurwitz CA, Crist WM.
    Leukemia; 1993 Jan 15; 7(1):35-40. PubMed ID: 8418377
    [Abstract] [Full Text] [Related]

  • 28. Multiparametric flow cytometry in detection of minimal residual disease in acute lymphoblastic leukemia of early B-cell phenotype.
    Mlcáková A, Babusíková O.
    Neoplasma; 2003 Jan 15; 50(6):416-21. PubMed ID: 14689062
    [Abstract] [Full Text] [Related]

  • 29. [Leukemia-associated immunophenotypes in 415 childhood and adult patients with B lineage acute lymphoblastic leukemia by multiparametric flow cytometry analysis].
    Liu YR, Chen SS, Chang Y, Fu JY, Zhang LP, Wang H, Li LD, Zhu HH, Liu GL, Lu DP, Huang XJ.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Oct 15; 14(5):853-7. PubMed ID: 17096875
    [Abstract] [Full Text] [Related]

  • 30. The knowledge on the 3rd type hematogones could contribute to more precise detection of small numbers of precursor B-acute lymphoblastic leukemia.
    Babusíková O, Zelezníková T, Mlcáková A, Kusenda J, Stevulová L.
    Neoplasma; 2005 Oct 15; 52(6):502-9. PubMed ID: 16284697
    [Abstract] [Full Text] [Related]

  • 31. Precursor B-cell lymphoblastic lymphoma. A study of nine cases lacking blood and bone marrow involvement and review of the literature.
    Maitra A, McKenna RW, Weinberg AG, Schneider NR, Kroft SH.
    Am J Clin Pathol; 2001 Jun 15; 115(6):868-75. PubMed ID: 11392884
    [Abstract] [Full Text] [Related]

  • 32. High expression of CEACAM6 and CEACAM8 mRNA in acute lymphoblastic leukemias.
    Lasa A, Serrano E, Carricondo M, Carnicer MJ, Brunet S, Badell I, Sierra J, Aventín A, Nomdedéu JF.
    Ann Hematol; 2008 Mar 15; 87(3):205-11. PubMed ID: 17909799
    [Abstract] [Full Text] [Related]

  • 33. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
    Babusíková O, Mesárosová A, Koníková M, Kusenda J, Glasová M, Klobusická M.
    Neoplasma; 1993 Mar 15; 40(5):275-81. PubMed ID: 8272155
    [Abstract] [Full Text] [Related]

  • 34. Flow cytometric analysis of BCL-2 can distinguish small numbers of acute lymphoblastic leukaemia cells from B-cell precursors.
    Hartung L, Bahler DW.
    Br J Haematol; 2004 Oct 15; 127(1):50-8. PubMed ID: 15384977
    [Abstract] [Full Text] [Related]

  • 35. Multiparametric analysis of normal and postchemotherapy bone marrow: Implication for the detection of leukemia-associated immunophenotypes.
    Olaru D, Campos L, Flandrin P, Nadal N, Duval A, Chautard S, Guyotat D.
    Cytometry B Clin Cytom; 2008 Jan 15; 74(1):17-24. PubMed ID: 18061947
    [Abstract] [Full Text] [Related]

  • 36. [Application of effective antigen combinations in childhood B lineage acute lymphoblastic leukemia].
    Liu Y, Tang JY, Xu C, Gu LJ, Xue HL, Chen J, Pan C, Dong L, Zhou M.
    Zhonghua Er Ke Za Zhi; 2009 May 15; 47(5):366-70. PubMed ID: 19573409
    [Abstract] [Full Text] [Related]

  • 37. Benign hematogone-rich lymphoid proliferations can be distinguished from B-lineage acute lymphoblastic leukemia by integration of morphology, immunophenotype, adhesion molecule expression, and architectural features.
    Rimsza LM, Larson RS, Winter SS, Foucar K, Chong YY, Garner KW, Leith CP.
    Am J Clin Pathol; 2000 Jul 15; 114(1):66-75. PubMed ID: 10884801
    [Abstract] [Full Text] [Related]

  • 38. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].
    Liu YR, Wang YZ, Chen SS, Chang Y, Fu JY, Li LD, Wang H, Yu H, Jiang B, Huang XJ.
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov 15; 28(11):731-6. PubMed ID: 18457262
    [Abstract] [Full Text] [Related]

  • 39. [CD10(CALLA)-negative acute lymphoblastic leukemia. A group with a bad prognosis].
    De Salvo L, Plumacher Z, Ríos M, Romero E, Weir J, Gómez O, Salas D.
    Invest Clin; 1992 Nov 15; 33(4):147-52. PubMed ID: 1303674
    [Abstract] [Full Text] [Related]

  • 40. Early diagnosis of smoldering acute lymphoblastic leukemia using immunological marker analysis.
    Knulst AC, Adriaansen HJ, Hählen K, Stigter JC, van den Beemd MW, Hagemeijer A, van Dongen JJ, Hooijkaas H.
    Leukemia; 1993 Apr 15; 7(4):532-6. PubMed ID: 8464231
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 4.